| Pharmaceutical Information |
| Drug Name |
Lincomycin hydrochloride |
| Drug ID |
BADD_D01293 |
| Description |
Lincomycin is a lincosamide antibiotic first isolated from the soil bacterium _Streptomyces lincolnensis_ in Lincoln, Nebraska.[A190621] Clinical use of lincomycin has largely been superseded by its semisynthetic derivative [clindamycin] due to its higher efficacy and a wider range of susceptible organisms, though lincomycin remains in use.[A190657, A190621]
Lincomycin was approved by the FDA on December 29, 1964.[L33214] |
| Indications and Usage |
Lincomycin is an antibiotic used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
J01FF02 |
| DrugBank ID |
DB01627
|
| KEGG ID |
D02346
|
| MeSH ID |
D008034
|
| PubChem ID |
64710
|
| TTD Drug ID |
D0Q0EX
|
| NDC Product Code |
42881-0001; 39822-0350; 39822-0353; 52584-353; 0009-0555; 50090-4533; 20076-0404; 0404-9901; 51927-3177; 0009-5168; 43781-2301; 55043-001 |
| Synonyms |
Lincomycin | Lincomycin A | Lincolnensin | Lincomycin Hydrochloride | Lincomycin Monohydrochloride | Lincomycin, (L-threo)-Isomer | Epilincomycin | Lincomycin Monohydrochloride, (L-threo)-Isomer | Lincomycin Monohydrochloride, Hemihydrate | Hemihydrate Lincomycin Monohydrochloride | Lincomycin, (2S-cis)-Isomer | Lincocin | Lincomycin Monohydrochloride, (2S-cis)-Isomer |
|
| Chemical Information |
| Molecular Formula |
C18H35ClN2O6S |
| CAS Registry Number |
859-18-7 |
| SMILES |
CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)O.Cl |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
